Dissemination (Spotlight)

The addition of pembrolizumab to standard chemotherapy with a platinum-based drug and pemetrexed resulted in improved overall survival, progression-free survival, and tumor response rate among patients with previously untreated...

We recently spoke with Raman Muthusamy, MD, MAS, professor of medicine and medical director of endoscopy at UCLA Health, about current treatment alternatives for patients with GERD who are either failing medical treatment or...

This study states that Immune checkpoint inhibitors (ICPIs) have transformed the treatment of lung cancer in the recent years. However, disruption in immune homeostasis produces a unique spectrum of side effects termed as...